Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2000)
Antimicrob Agents Chemother
A. Carta, S. Piras, M. Palomba, D. Jabes, P. Molicotti, S. Zanetti (2008)
Anti-Mycobacterial Activity of Quinolones. Triazoloquinolones a New Class of Potent Anti-Mycobacterial AgentsAnti-Infective Agents in Medicinal Chemistry, 7
L. Barrera, E. Cooreman, J. Iragena, F. Drobniewski, P. Duda, M. Havelkova, S. Hoffner, K. Kam, Kim Sj, S. Labelle, K. Lambregts, V. Leimane, Paul Nunn, A. Ramsay, M. Raviglione, M. Rich, J. Ridderhof, F. Rodrigues, S. Rüsch-Gerdes, M. Salfinger, J. Scholten, N. Selvakumar, T. Shinnick, M. Shulgina, G. Skenders, A. Sloutsky, P. Small, A. Deun, F. Varaine, M. Yagui, Véronique Vincent, K. Weyer, A. Wright, M. Zignol (2008)
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
M. Ruíz-Serrano, L. Alcalá, L. Martinez, M. Díaz, M. Marín, M. González-Abad, E. Bouza (2000)
In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosisSusceptible or Resistant to First-Line Antituberculosis DrugsAntimicrobial Agents and Chemotherapy, 44
A. Ginsburg, J. Grosset, W. Bishai (2003)
Fluoroquinolones, tuberculosis, and resistance.The Lancet. Infectious diseases, 3 7
(2006)
Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas
K. Dooley, J. Golub, F. Goes, W. Merz, T. Sterling (2002)
Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 12
Chih-Cheng Lai, Che-kim Tan, Yu-Tsung Huang, C. Chou, C. Hung, Pan‐Chyr Yang, K. Luh, P. Hsueh (2008)
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 47 7
S. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. Gordon, K. Eiglmeier, S. Gas, C. Barry, F. Tekaia, K. Badcock, D. Basham, David Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. Mclean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. Quail, M. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. Sulston, K. Taylor, S. Whitehead, B. Barrell (1998)
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 393
Luke Lin (2007)
Analysis of Antibacterial Response of Nemonoxacin (TG-873870) Against Major Pathogens from Respiratory Tract and Skin Infections
Journal of Antimicrobial Chemotherapy (2009) 64, 428–435 doi:10.1093/jac/dkp174 Advance Access publication 19 May 2009 In total, 109 non-duplicate and consecutive TB isolates, Comparative in vitro activities of the new recovered from various clinical specimens, were collected from quinolone nemonoxacin (TG-873870), gemifloxacin 2000 to 2007 at the National Taiwan University Hospital and other quinolones against clinical isolates of (NTUH). Susceptibility to first-line anti-TB drugs, including iso- Mycobacterium tuberculosis niazid (0.2 and 1.0 mg/L), rifampicin (1 mg/L) and ethambutol 1 2 3 (5 mg/L), and second-line anti-TB drugs, including streptomycin Che-Kim Tan , Chih-Cheng Lai , Chun-Hsing Liao , 4 5 5,6 (2 and 10 mg/L), rifabutin (0.5 mg/L), ofloxacin (2 mg/L), Chien-Hong Chou , Hsiao-Leng Hsu , Yu-Tsung Huang 5,6 ethionamide (5 mg/L) and para-aminosalicylic acid (2 mg/L), and Po-Ren Hsueh * was determined in the Mycobacteriology Laboratory of NTUH using modified, proportional, disc elution methods. A Department of Intensive Care Medicine, Chi-Mei Medical M. tuberculosis suspension was inoculated onto Middlebrook Center, Tainan, Taiwan; Department of Internal Medicine, 7H10 agar (BBL Microbiology Systems, Cockeysville, MD, USA) Yi-Min Hospital, Taipei, Taiwan; Department of Internal that contained anti-TB drugs at respective concentrations. The Medicine, Far Eastern Memorial Hospital, Taipei County, tested isolate
Journal of Antimicrobial Chemotherapy – Oxford University Press
Published: Aug 19, 2009
Keywords: M. tuberculosis TB MDR-TB
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.